- Changes in the expression of vimentin in the testes of busulfan treated rats2003 | Faculty of Pharmacy in Hradec Králové
- The changes of expression of P- and E-cadherin in the cryptorchic and busulfan treated rat testis +1Publication without faculty affiliation
- Area under the concentration versus time curve (AUC) based busulfan exposure monitoring in paediatric patients2009 | Publication without faculty affiliation
- Therapeutic drug monitoring (TDM) uncovers unrealability of the first dose to predict busulfan next doses for haemopoietic stem cell transplantation conditioning therapy: A case study2012 | Publication without faculty affiliation
- Determination of busulfan using high-performance liquid chromatography with fluorescence detectionPublication without faculty affiliation
- Busulfan bioavailibility1994 | Second Faculty of Medicine
- Changes in the expression of P-cadherin in the normal, cryptorchid and busulphan-treated rat testis2007 | Publication without faculty affiliation
- Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trial2024 | Second Faculty of Medicine
- Area under the concentrations versus time curve (AUC) based busulfan exposure monitoring in paediatric patients2009 | Second Faculty of Medicine
- Clinical pharmacology of high-dose busulfan in patients undergoing bone-marrow transplantation - improved clinical outcome due to indivadualized dosingPublication without faculty affiliation
- Current challenges of body weight based intravenous busulfan dosing versus dose adjustment based on therapeutic drug monitoring2013 | Second Faculty of Medicine
- The importance of Therapeutic Drug Monitoring (TDM) for parenteral busulfan dosing in conditioning regimen for Hematopoietic Stem Cell Transplantation (HSCT) in children2014 | Second Faculty of Medicine
- GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study2017 | Second Faculty of Medicine
- Measurement of Serum Ibuprofen and Busulfanum in High Dose Therapy1999 | Second Faculty of Medicine
- Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)2023 | Faculty of Medicine in Hradec Králové
- Reduced-Intensity Conditioning With Fludarabine and Busulfan Versus Fludarabine and Melphalan for Patients With Acute Myeloid Leukemia: A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation2015 | Publication without faculty affiliation
- Total body irradiation plus fludarabine compared to busulfan plus fludarabine as "reduced-toxicity conditioning" for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT2021 | Faculty of Medicine in Hradec Králové
- Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial2017 | Second Faculty of Medicine
- Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation : a prospective randomized trial2007 | First Faculty of Medicine
- Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation : a prospective randomized trial2007 | Faculty of Physical Education and Sport
- Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood1996 | Second Faculty of Medicine
- Allogenic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: A report from the European Working Group on Myelodysplastic Syndrome in Childhood1997 | Second Faculty of Medicine
- Hematopoietic stem cell transplantation for children with acute myeloid leukemia-results of the AML SCT-BFM 2007 trial2020 | Second Faculty of Medicine
- Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience2016 | Second Faculty of Medicine
- Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation2017 | Second Faculty of Medicine
- Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases2015 | Second Faculty of Medicine
- Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure2007 | Second Faculty of Medicine
- High-dose chemotherapy in the treatment of malignant lymphoma in children2000 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Successful transplantation of umbilical blood in a boy with the syndrome of leucocyte adhesion deficiency1996 | Second Faculty of Medicine